American Analyst Updates: Nov 4th, 2026

Analyst Ratings (USA)

Wall Street analyst outlookt was mixed today, but leaned cautious, with downgrades outnumbering upgrades across several major sectors. Technology showed diverging trends, as analysts expressed increased optimism toward AI infrastructure, semiconductors, and cybersecurity, while Adobe and Apple faced rating downgrades amid valuation and growth concerns. AMD continued to attract favourable analyst coverage, although price target revisions were mixed. Financial services, automotive, consumer discretionary, and cryptocurrency-related stocks experienced increased downward revisions, reflecting concerns over profitability, demand, and near-term earnings expectations. Healthcare and industrial companies received selective upgrades, while new coverage highlighted opportunities in defence, cybersecurity, and biotechnology.

Updates (653)

3M (MMM) — JPMorgan Chase & Co. raised its price target for the stock from $191.00 to $210.00 while maintaining an Overweight rating.

3M (MMM) — UBS Group set a price target of $230.00.

Aardvark Therapeutics (AARD) — Raymond James Financial downgraded the stock from Strong-Buy to Market Perform.

AbbVie (ABBV) — BMO Capital Markets set a price target of $315.00.

AdaptHealth (AHCO) — UBS Group lowered its price target for the stock from $10.00 to $9.00 while maintaining a Buy rating.

Addus HomeCare (ADUS) — Barclays raised its price target for the stock from $96.00 to $101.00 while maintaining an Underweight rating.

Adobe (ADBE) — Citigroup downgraded the stock from Neutral to Sell, adjusting its price target from $250.00 to $207.00.

ADT (ADT) — Barclays upgraded the stock from Underweight to Equal Weight, with a price target of $10.00.

ADTRAN (ADTN) — B. Riley Financial reiterated its Buy rating, and revised its price target from $21.00 to $14.00.

Advanced Micro Devices (AMD) — Bank of America lowered its price target for the stock from $720.00 to $650.00 while maintaining a Buy rating.

Advanced Micro Devices (AMD) — Cantor Fitzgerald reiterated its Overweight rating, with a price target of $700.00.

Advanced Micro Devices (AMD) — DA Davidson raised its price target for the stock from $550.00 to $600.00 while maintaining a Buy rating.

Advanced Micro Devices (AMD) — JPMorgan Chase & Co. raised its price target for the stock from $550.00 to $575.00 while maintaining a Neutral rating.

Advanced Micro Devices (AMD) — KeyCorp reiterated its Overweight rating, with a price target of $725.00.

Advanced Micro Devices (AMD) — Melius Research set a price target of $650.00.

Advanced Micro Devices (AMD) — Mizuho lowered its price target for the stock from $705.00 to $610.00 while maintaining an Outperform rating.

Advanced Micro Devices (AMD) — Piper Sandler raised its price target for the stock from $600.00 to $650.00 while maintaining an Overweight rating.

Advanced Micro Devices (AMD) — Raymond James Financial reiterated its Strong-Buy rating, with a price target of $649.00.

Advanced Micro Devices (AMD) — Rosenblatt Securities reiterated its Buy rating, with a price target of $700.00.

Advanced Micro Devices (AMD) — Royal Bank Of Canada reiterated its Sector Perform rating, with a price target of $540.00.

Advanced Micro Devices (AMD) — Royal Bank Of Canada set a price target of $675.00.

Advanced Micro Devices (AMD) — Sanford C. Bernstein reiterated its Outperform rating.

Advanced Micro Devices (AMD) — Stifel Nicolaus raised its price target for the stock from $700.00 to $725.00 while maintaining a Buy rating.

Advanced Micro Devices (AMD) — The Goldman Sachs Group reiterated its Buy rating, with a price target of $675.00.

Advanced Micro Devices (AMD) — Truist Financial raised its price target for the stock from $594.00 to $605.00 while maintaining a Buy rating.

Advanced Micro Devices (AMD) — UBS Group lowered its price target for the stock from $730.00 to $700.00 while maintaining a Buy rating.

Advanced Micro Devices (AMD) — Unknown brokerage reiterated its Positive rating.

Advanced Micro Devices (AMD) — Wedbush reiterated its Outperform rating, with a price target of $600.00.

Advanced Micro Devices (AMD) — Wells Fargo & Company lowered its price target for the stock from $700.00 to $650.00 while maintaining an Overweight rating.

Advanced Micro Devices (AMD) — William Blair reiterated its Market Perform rating.

Advanced Micro Devices (AMD) — Wolfe Research reiterated its Outperform rating, with a price target of $650.00.

AG Mortgage Investment Trust (MITT) — JonesTrading lowered its price target for the stock from $8.00 to $7.00 while maintaining a Buy rating.

AGCO (AGCO) — Morgan Stanley raised its price target for the stock from $99.00 to $113.00 while maintaining an Underweight rating.

Alight (ALIT) — Needham & Company LLC reiterated its Hold rating.

Alkermes (ALKS) — HC Wainwright raised its price target for the stock from $43.00 to $50.00 while maintaining a Neutral rating.

Alkermes (ALKS) — Robert W. Baird set a price target of $34.00 to $36.00 with a Buy rating.

Alkermes (ALKS) — Royal Bank Of Canada raised its price target for the stock from $56.00 to $57.00 while maintaining an Outperform rating.

Alkermes (ALKS) — Wells Fargo & Company raised its price target for the stock from $65.00 to $68.00 while maintaining an Overweight rating.

Allison Transmission (ALSN) — Citigroup raised its price target for the stock from $135.00 to $140.00 while maintaining a Buy rating.

Allison Transmission (ALSN) — Morgan Stanley raised its price target for the stock from $132.00 to $139.00 while maintaining an Equal Weight rating.

Alphatec (ATEC) — UBS Group downgraded the stock from Buy to Neutral, adjusting its price target from $15.00 to $8.50.

Amdocs (DOX) — Oppenheimer downgraded the stock from Outperform to Market Perform.

Amdocs (DOX) — Stifel Nicolaus lowered its price target for the stock from $71.00 to $46.00 while maintaining a Buy rating.

American International Group (AIG) — Bank of America reiterated its Neutral rating.

American Well (AMWL) — Stifel Nicolaus raised its price target for the stock from $11.00 to $12.00 while maintaining a Hold rating.

American Well (AMWL) — TD Cowen raised its price target for the stock from $12.00 to $13.00 while maintaining a Hold rating.

American Well (AMWL) — Wells Fargo & Company raised its price target for the stock from $16.00 to $18.00 while maintaining an Overweight rating.

AMETEK (AME) — Citigroup raised its price target for the stock from $263.00 to $270.00 while maintaining a Neutral rating.

AMETEK (AME) — Mizuho lowered its price target for the stock from $285.00 to $275.00 while maintaining an Outperform rating.

AMETEK (AME) — Royal Bank Of Canada raised its price target for the stock from $291.00 to $308.00 while maintaining an Outperform rating.

Amgen (AMGN) — Canaccord Genuity Group raised its price target for the stock from $384.00 to $440.00 while maintaining a Hold rating.

Amgen (AMGN) — Cantor Fitzgerald raised its price target for the stock from $440.00 to $465.00 while maintaining a Neutral rating.

Amgen (AMGN) — Citigroup raised its price target for the stock from $405.00 to $465.00 while maintaining a Neutral rating.

Amgen (AMGN) — JPMorgan Chase & Co. raised its price target for the stock from $350.00 to $425.00 while maintaining a Neutral rating.

Amgen (AMGN) — Morgan Stanley raised its price target for the stock from $359.00 to $410.00 while maintaining an Equal Weight rating.

Amgen (AMGN) — Royal Bank Of Canada raised its price target for the stock from $430.00 to $470.00 while maintaining an Outperform rating.

Amgen (AMGN) — Sanford C. Bernstein reiterated its Market Perform rating, with a price target of $400.00.

Amgen (AMGN) — Scotiabank raised its price target for the stock from $500.00 to $530.00 while maintaining a Sector Outperform rating.

Amgen (AMGN) — TD Cowen raised its price target for the stock from $452.00 to $531.00 while maintaining a Buy rating.

Amgen (AMGN) — The Goldman Sachs Group raised its price target for the stock from $481.00 to $536.00 while maintaining a Buy rating.

Amgen (AMGN) — Truist Financial raised its price target for the stock from $380.00 to $398.00 while maintaining a Hold rating.

Amgen (AMGN) — UBS Group raised its price target for the stock from $470.00 to $530.00 while maintaining a Buy rating.

Amgen (AMGN) — Wells Fargo & Company raised its price target for the stock from $430.00 to $460.00 while maintaining an Equal Weight rating.

Amgen (AMGN) — William Blair reiterated its Outperform rating.

Amneal Pharmaceuticals (AMRX) — JPMorgan Chase & Co. raised its price target for the stock from $24.00 to $25.00 while maintaining an Overweight rating.

Amneal Pharmaceuticals (AMRX) — Piper Sandler reiterated its Overweight rating, with a price target of $21.00.

Angel Oak Mortgage REIT (AOMR) — B. Riley Financial lowered its price target for the stock from $13.00 to $10.00 while maintaining a Buy rating.

Apollo Global Management (APO) — Barclays lowered its price target for the stock from $157.00 to $156.00 while maintaining an Overweight rating.

Apollo Global Management (APO) — JPMorgan Chase & Co. raised its price target for the stock from $153.00 to $157.00 while maintaining an Overweight rating.

Apollo Global Management (APO) — Keefe, Bruyette & Woods lowered its price target for the stock from $135.00 to $130.00 while maintaining a Market Perform rating.

Apollo Global Management (APO) — Morgan Stanley lowered its price target for the stock from $150.00 to $149.00 while maintaining an Overweight rating.

Apollo Global Management (APO) — Piper Sandler reiterated its Overweight rating, with a price target of $145.00.

Apollo Global Management (APO) — Royal Bank Of Canada lowered its price target for the stock from $146.00 to $138.00 while maintaining a Sector Perform rating.

Apollo Global Management (APO) — TD Cowen lowered its price target for the stock from $154.00 to $136.00 while maintaining a Buy rating.

Apple (AAPL) — DZ Bank downgraded the stock from Hold to Sell, with a price target of $300.00.

Apple (AAPL) — The Goldman Sachs Group set a price target of $380.00.

Aptiv (APTV) — Barclays lowered its price target for the stock from $60.00 to $53.00 while maintaining an Overweight rating.

Aptiv (APTV) — BNP Paribas Exane reiterated its Outperform rating, and revised its price target from $63.00 to $59.00.

Aptiv (APTV) — Morgan Stanley lowered its price target for the stock from $55.00 to $45.00 while maintaining an Equal Weight rating.

Aptiv (APTV) — Royal Bank Of Canada lowered its price target for the stock from $77.00 to $64.00 while maintaining an Outperform rating.

Aptiv (APTV) — TD Cowen lowered its price target for the stock from $77.00 to $72.00 while maintaining a Buy rating.

Aptiv (APTV) — The Goldman Sachs Group lowered its price target for the stock from $61.00 to $54.00 while maintaining a Buy rating.

ArcBest (ARCB) — Jefferies Financial Group reiterated its Buy rating.

ArcBest (ARCB) — TD Cowen reiterated its Hold rating.

Archer Daniels Midland (ADM) — JPMorgan Chase & Co. upgraded the stock from Underweight to Neutral, with a price target of $75.00.

Archer Daniels Midland (ADM) — Stephens lowered its price target for the stock from $85.00 to $75.00 while maintaining an Equal Weight rating.

Arista Networks (ANET) — Barclays lowered its price target for the stock from $289.00 to $236.00 while maintaining an Overweight rating.

Arista Networks (ANET) — JPMorgan Chase & Co. raised its price target for the stock from $250.00 to $270.00 while maintaining an Overweight rating.

Arista Networks (ANET) — Melius Research set a price target of $305.00.

Arista Networks (ANET) — Morgan Stanley reiterated its Overweight rating, and revised its price target from $220.00 to $230.00.

Arista Networks (ANET) — Needham & Company LLC reiterated its Buy rating, with a price target of $260.00.

Arista Networks (ANET) — Piper Sandler raised its price target for the stock from $240.00 to $261.00 while maintaining an Overweight rating.

Arista Networks (ANET) — Rosenblatt Securities reiterated its Buy rating, with a price target of $280.00.

Arista Networks (ANET) — Truist Financial raised its price target for the stock from $234.00 to $240.00 while maintaining a Buy rating.

Arista Networks (ANET) — UBS Group reiterated its Buy rating, and revised its price target from $259.00 to $291.00.

Arista Networks (ANET) — Wells Fargo & Company reiterated its Overweight rating, and revised its price target from $255.00 to $245.00.

Astera Labs (ALAB) — Morgan Stanley raised its price target for the stock from $382.00 to $389.00 while maintaining an Overweight rating.

Astera Labs (ALAB) — Needham & Company LLC lowered its price target for the stock from $425.00 to $300.00 while maintaining a Buy rating.

Astera Labs (ALAB) — Northland Securities upgraded the stock from Market Perform to Outperform, with a price target of $315.00.

Astera Labs (ALAB) — Royal Bank Of Canada lowered its price target for the stock from $500.00 to $400.00 while maintaining an Outperform rating.

Astera Labs (ALAB) — Susquehanna lowered its price target for the stock from $310.00 to $258.00 while maintaining a Neutral rating.

Astera Labs (ALAB) — TD Cowen lowered its price target for the stock from $300.00 to $225.00 while maintaining a Hold rating.

Astera Labs (ALAB) — UBS Group lowered its price target for the stock from $300.00 to $290.00 while maintaining a Neutral rating.

Atlas Energy Solutions (AESI) — Piper Sandler lowered its price target for the stock from $15.00 to $13.00 while maintaining a Neutral rating.

Atlas Energy Solutions (AESI) — Royal Bank Of Canada lowered its price target for the stock from $16.00 to $13.00 while maintaining a Sector Perform rating.

Atlas Energy Solutions (AESI) — Scotiabank raised its price target for the stock from $17.00 to $18.00 while maintaining a Sector Outperform rating.

AtriCure (ATRC) — BTIG Research raised its price target for the stock from $63.00 to $70.00 while maintaining a Buy rating.

AtriCure (ATRC) — Canaccord Genuity Group raised its price target for the stock from $55.00 to $67.00 while maintaining a Buy rating.

AtriCure (ATRC) — JPMorgan Chase & Co. raised its price target for the stock from $36.00 to $62.00 while maintaining a Neutral rating.

AtriCure (ATRC) — Needham & Company LLC raised its price target for the stock from $64.00 to $70.00 while maintaining a Buy rating.

AtriCure (ATRC) — Piper Sandler reiterated its Overweight rating, and revised its price target from $60.00 to $70.00.

AutoNation (AN) — JPMorgan Chase & Co. downgraded the stock from Overweight to Neutral, with a price target of $185.00.

Avis Budget Group (CAR) — Susquehanna reiterated its Neutral rating, with a price target of $125.00.

Axsome Therapeutics (AXSM) — Mizuho lowered its price target for the stock from $284.00 to $272.00 while maintaining an Outperform rating.

Ball (BALL) — JPMorgan Chase & Co. downgraded the stock from Overweight to Neutral, with a price target of $65.00.

Ball (BALL) — Mizuho raised its price target for the stock from $72.00 to $75.00 while maintaining an Outperform rating.

Ball (BALL) — Truist Financial reiterated its Buy rating, and revised its price target from $78.00 to $76.00.

Ball (BALL) — UBS Group raised its price target for the stock from $63.00 to $68.00 while maintaining a Neutral rating.

Beam Therapeutics (BEAM) — Canaccord Genuity Group lowered its price target for the stock from $79.00 to $78.00 while maintaining a Buy rating.

Beam Therapeutics (BEAM) — Wedbush raised its price target for the stock from $28.00 to $30.00 while maintaining an Outperform rating.

BETA Technologies (BETA) — Cantor Fitzgerald reiterated its Overweight rating, with a price target of $31.00.

BETA Technologies (BETA) — Needham & Company LLC lowered its price target for the stock from $34.00 to $28.00 while maintaining a Buy rating.

BioMarin Pharmaceutical (BMRN) — JPMorgan Chase & Co. lowered its price target for the stock from $87.00 to $86.00 while maintaining an Overweight rating.

BioNTech (BNTX) — Bank of America reiterated its Buy rating.

BioNTech (BNTX) — Morgan Stanley lowered its price target for the stock from $114.00 to $106.00 while maintaining an Overweight rating.

BioNTech (BNTX) — UBS Group lowered its price target for the stock from $135.00 to $125.00 while maintaining a Buy rating.

BioNTech (BNTX) — Wells Fargo & Company lowered its price target for the stock from $140.00 to $125.00 while maintaining an Overweight rating.

Block (XYZ) — Bank of America raised its price target for the stock from $115.00 to $117.00 while maintaining a Buy rating.

Block (XYZ) — Citizens Jmp reiterated its Market Perform rating.

Block (XYZ) — Morgan Stanley raised its price target for the stock from $80.00 to $82.00 while maintaining an Equal Weight rating.

Block (XYZ) — Needham & Company LLC reiterated its Buy rating, with a price target of $100.00.

Block (XYZ) — Royal Bank Of Canada raised its price target for the stock from $95.00 to $103.00 while maintaining an Outperform rating.

Block (XYZ) — Scotiabank raised its price target for the stock from $82.00 to $89.00 while maintaining a Sector Perform rating.

Block (XYZ) — Susquehanna raised its price target for the stock from $100.00 to $110.00 while maintaining a Positive rating.

Block (XYZ) — TD Cowen raised its price target for the stock from $105.00 to $109.00 while maintaining a Buy rating.

Blue Owl Capital (OWL) — Raymond James Financial reiterated its Strong-Buy rating, with a price target of $15.00.

Boise Cascade (BCC) — Truist Financial lowered its price target for the stock from $97.00 to $86.00 while maintaining a Buy rating.

Booking (BKNG) — B. Riley Financial lowered its price target for the stock from $274.00 to $265.00 while maintaining a Buy rating.

Booking (BKNG) — Bank of America lowered its price target for the stock from $232.00 to $219.00 while maintaining a Buy rating.

Booking (BKNG) — Barclays lowered its price target for the stock from $210.00 to $170.00 while maintaining an Overweight rating.

Booking (BKNG) — BMO Capital Markets reiterated its Outperform rating, with a price target of $245.00.

Booking (BKNG) — BTIG Research reiterated its Buy rating, with a price target of $250.00.

Booking (BKNG) — Cantor Fitzgerald lowered its price target for the stock from $170.00 to $150.00 while maintaining a Neutral rating.

Booking (BKNG) — Citigroup reiterated its Outperform rating.

Booking (BKNG) — Citigroup lowered its price target for the stock from $236.00 to $220.00 while maintaining a Buy rating.

Booking (BKNG) — Citizens Jmp reiterated its Market Perform rating.

Booking (BKNG) — JPMorgan Chase & Co. lowered its price target for the stock from $248.00 to $205.00 while maintaining an Overweight rating.

Booking (BKNG) — Mizuho set a price target of $205.00.

Booking (BKNG) — Morgan Stanley reiterated its Overweight rating, and revised its price target from $230.00 to $200.00.

Booking (BKNG) — Piper Sandler reiterated its Neutral rating, and revised its price target from $215.00 to $200.00.

Booking (BKNG) — Rosenblatt Securities lowered its price target for the stock from $245.00 to $210.00 while maintaining a Buy rating.

Booking (BKNG) — Royal Bank Of Canada lowered its price target for the stock from $220.00 to $205.00 while maintaining an Outperform rating.

Booking (BKNG) — Susquehanna reiterated its Positive rating, and revised its price target from $240.00 to $200.00.

Booking (BKNG) — The Goldman Sachs Group reiterated its Neutral rating, with a price target of $175.00.

Booking (BKNG) — Wedbush lowered its price target for the stock from $247.00 to $210.00 while maintaining an Outperform rating.

Booking (BKNG) — Wells Fargo & Company reiterated its Positive rating, and revised its price target from $190.00 to $179.00.

Broadridge Financial Solutions (BR) — JPMorgan Chase & Co. raised its price target for the stock from $191.00 to $201.00 while maintaining a Neutral rating.

Broadridge Financial Solutions (BR) — Morgan Stanley raised its price target for the stock from $176.00 to $181.00 while maintaining an Equal Weight rating.

Cabot (CBT) — Truist Financial lowered its price target for the stock from $100.00 to $95.00 while maintaining a Buy rating.

Cabot (CBT) — UBS Group lowered its price target for the stock from $86.00 to $80.00 while maintaining a Neutral rating.

Calix (CALX) — JPMorgan Chase & Co. lowered its price target for the stock from $58.00 to $50.00 while maintaining an Overweight rating.

Calix (CALX) — Rosenblatt Securities reiterated its Buy rating, with a price target of $55.00.

Camping World (CWH) — Citigroup downgraded the stock from Buy to Neutral, adjusting its price target from $7.00 to $5.00.

Camping World (CWH) — KeyCorp lowered its price target for the stock from $8.00 to $7.00 while maintaining an Overweight rating.

Camtek (CAMT) — Needham & Company LLC lowered its price target for the stock from $170.00 to $130.00 while maintaining a Buy rating.

Camtek (CAMT) — Stifel Nicolaus set a price target of $140.00.

CarMax (KMX) — JPMorgan Chase & Co. lowered its price target for the stock from $70.00 to $65.00 while maintaining a Neutral rating.

CarMax (KMX) — Mizuho set a price target of $50.00.

Celanese (CE) — Barclays raised its price target for the stock from $49.00 to $57.00 while maintaining an Equal Weight rating.

Celanese (CE) — Citigroup raised its price target for the stock from $58.00 to $65.00 while maintaining a Buy rating.

Celanese (CE) — JPMorgan Chase & Co. raised its price target for the stock from $76.00 to $77.00 while maintaining an Overweight rating.

Central Bancompany (CBC) — Bank of America downgraded the stock from Buy to Neutral, with a price target of $36.50.

CeriBell (CBLL) — BTIG Research reiterated its Buy rating.

CeriBell (CBLL) — Canaccord Genuity Group raised its price target for the stock from $26.00 to $33.00 while maintaining a Buy rating.

Chemours (CC) — Truist Financial lowered its price target for the stock from $20.00 to $18.00 while maintaining a Buy rating.

Chemours (CC) — UBS Group lowered its price target for the stock from $16.00 to $15.00 while maintaining a Neutral rating.

Cinemark (CNK) — Wedbush raised its price target for the stock from $45.00 to $46.00 while maintaining an Outperform rating.

Cinemark (CNK) — Wells Fargo & Company raised its price target for the stock from $34.00 to $42.00 while maintaining an Equal Weight rating.

Cipher Mining (CIFR) — Keefe, Bruyette & Woods downgraded the stock from Outperform to Market Perform, with a price target of $9.50.

Citizens (CIZN) — Citigroup reiterated its Market Perform rating.

Cleanspark (CLSK) — Keefe, Bruyette & Woods downgraded the stock from Outperform to Market Perform, with a price target of $9.50.

CLEAR Secure (YOU) — Needham & Company LLC raised its price target for the stock from $70.00 to $90.00 while maintaining a Buy rating.

CLEAR Secure (YOU) — The Goldman Sachs Group reiterated its Buy rating, with a price target of $80.00.

Clorox (CLX) — Morgan Stanley raised its price target for the stock from $87.00 to $94.00 while maintaining an Equal Weight rating.

Coca-Cola Europacific Partners (CCEP) — Sanford C. Bernstein reiterated its Market Perform rating, with a price target of $110.00.

Coca-Cola Europacific Partners (CCEP) — UBS Group raised its price target for the stock from $107.00 to $115.00 while maintaining a Neutral rating.

Coca-Cola Europacific Partners (CCEP) — Wells Fargo & Company raised its price target for the stock from $115.00 to $120.00 while maintaining an Overweight rating.

Columbus McKinnon (CMCO) — JPMorgan Chase & Co. raised its price target for the stock from $29.00 to $30.00 while maintaining an Overweight rating.

Community Health Systems (CYH) — Barclays lowered its price target for the stock from $2.50 to $2.00 while maintaining an Underweight rating.

Community West Bancshares (CWBC) — Keefe, Bruyette & Woods reiterated its Market Perform rating.

Compass Pathways (CMPS) — Royal Bank Of Canada reiterated its Outperform rating.

Compass Pathways (CMPS) — Wells Fargo & Company lowered its price target for the stock from $13.00 to $10.00 while maintaining an Equal Weight rating.

Constellation Brands (STZ) — Bank of America upgraded the stock from Underperform to Neutral, with a price target of $160.00.

Contineum Therapeutics (CTNM) — Stifel Nicolaus set a price target of $23.00.

COPT Defense Properties (CDP) — Citigroup lowered its price target for the stock from $40.00 to $36.00 while maintaining a Neutral rating.

Corcept Therapeutics (CORT) — Piper Sandler reiterated its Overweight rating, and revised its price target from $165.00 to $173.00.

Core & Main (CNM) — Jefferies Financial Group initiated coverage with a Buy rating and a $53.00 price target.

CoreWeave (CRWV) — Citigroup lowered its price target for the stock from $159.00 to $128.00 while maintaining a Buy rating.

Coupang (CPNG) — Citigroup upgraded the stock from Neutral to Buy, with a price target of $19.00.

Coupang (CPNG) — Mizuho set a price target of $21.00.

Crescent Energy (CRGY) — Truist Financial raised its price target for the stock from $19.00 to $20.00 while maintaining a Buy rating.

Crexendo (CXDO) — Needham & Company LLC reiterated its Buy rating.

CRH (CRH) — Morgan Stanley lowered its price target for the stock from $139.00 to $129.00 while maintaining an Overweight rating.

CRISPR Therapeutics (CRSP) — Citigroup raised its price target for the stock from $88.00 to $90.00 while maintaining a Buy rating.

CRISPR Therapeutics (CRSP) — Wells Fargo & Company lowered its price target for the stock from $75.00 to $70.00 while maintaining an Equal Weight rating.

Crown (CCK) — JPMorgan Chase & Co. downgraded the stock from Overweight to Neutral, with a price target of $121.00.

CubeSmart (CUBE) — UBS Group raised its price target for the stock from $38.00 to $44.00 while maintaining a Neutral rating.

CVS Health (CVS) — Evercore reiterated its Outperform rating.

CVS Health (CVS) — Jefferies Financial Group reiterated its Buy rating, with a price target of $103.00.

CVS Health (CVS) — Raymond James Financial reiterated its Outperform rating, with a price target of $120.00.

CVS Health (CVS) — TD Cowen reiterated its Buy rating.

CVS Health (CVS) — UBS Group set a price target of $110.00.

Datadog (DDOG) — BTIG Research lowered its price target for the stock from $289.00 to $260.00 while maintaining a Buy rating.

Datadog (DDOG) — Guggenheim reiterated its Buy rating.

Datadog (DDOG) — Jefferies Financial Group reiterated its Hold rating, with a price target of $230.00.

Datadog (DDOG) — Needham & Company LLC reiterated its Buy rating, with a price target of $300.00.

Datadog (DDOG) — Stifel Nicolaus set a price target of $245.00.

Denali Therapeutics (DNLI) — BTIG Research reiterated its Buy rating, with a price target of $39.00.

Denali Therapeutics (DNLI) — Morgan Stanley raised its price target for the stock from $40.00 to $42.00 while maintaining an Overweight rating.

Denali Therapeutics (DNLI) — Wedbush raised its price target for the stock from $23.00 to $24.00 while maintaining an Outperform rating.

Diamondback Energy (FANG) — Truist Financial raised its price target for the stock from $224.00 to $232.00 while maintaining a Buy rating.

Diamondback Energy (FANG) — UBS Group raised its price target for the stock from $256.00 to $260.00 while maintaining a Buy rating.

Diamondback Energy (FANG) — Wells Fargo & Company lowered its price target for the stock from $263.00 to $244.00 while maintaining an Overweight rating.

DigitalOcean (DOCN) — Barclays lowered its price target for the stock from $161.00 to $140.00 while maintaining an Overweight rating.

DigitalOcean (DOCN) — Canaccord Genuity Group lowered its price target for the stock from $200.00 to $180.00 while maintaining a Buy rating.

DigitalOcean (DOCN) — Citigroup lowered its price target for the stock from $190.00 to $160.00 while maintaining a Buy rating.

DigitalOcean (DOCN) — Morgan Stanley lowered its price target for the stock from $175.00 to $150.00 while maintaining an Overweight rating.

DigitalOcean (DOCN) — UBS Group lowered its price target for the stock from $105.00 to $100.00 while maintaining a Neutral rating.

Dine Brands Global (DIN) — Raymond James Financial reiterated its Market Perform rating.

Driven Brands (DRVN) — Barclays downgraded the stock from Equal Weight to Underweight, with a price target of $11.00.

Driven Brands (DRVN) — BTIG Research downgraded the stock from Buy to Neutral.

Duolingo (DUOL) — Barclays raised its price target for the stock from $115.00 to $133.00 while maintaining an Equal Weight rating.

Duolingo (DUOL) — Citigroup reiterated its Market Perform rating.

Duolingo (DUOL) — Citigroup raised its price target for the stock from $140.00 to $152.00 while maintaining a Neutral rating.

Duolingo (DUOL) — DA Davidson set a price target of $180.00.

Duolingo (DUOL) — Evercore set a price target of $128.00.

Duolingo (DUOL) — JPMorgan Chase & Co. raised its price target for the stock from $135.00 to $155.00 while maintaining a Neutral rating.

Duolingo (DUOL) — Morgan Stanley raised its price target for the stock from $140.00 to $145.00 while maintaining an Equal Weight rating.

Duolingo (DUOL) — Needham & Company LLC raised its price target for the stock from $145.00 to $165.00 while maintaining a Buy rating.

Duolingo (DUOL) — Scotiabank raised its price target for the stock from $120.00 to $140.00 while maintaining a Sector Perform rating.

Duolingo (DUOL) — The Goldman Sachs Group set a price target of $128.00.

Duolingo (DUOL) — UBS Group raised its price target for the stock from $150.00 to $180.00 while maintaining a Buy rating.

Duolingo (DUOL) — Wedbush raised its price target for the stock from $150.00 to $155.00 while maintaining a Neutral rating.

Duolingo (DUOL) — Wells Fargo & Company upgraded the stock from Underweight to Equal Weight, adjusting its price target from $80.00 to $120.00.

DuPont de Nemours (DD) — Barclays raised its price target for the stock from $156.00 to $176.00 while maintaining an Overweight rating.

DuPont de Nemours (DD) — Citigroup raised its price target for the stock from $162.00 to $176.00 while maintaining a Buy rating.

DuPont de Nemours (DD) — UBS Group raised its price target for the stock from $172.00 to $182.00 while maintaining a Buy rating.

Dynatrace (DT) — Barclays lowered its price target for the stock from $71.00 to $61.00 while maintaining an Overweight rating.

Dynatrace (DT) — Citigroup lowered its price target for the stock from $75.00 to $70.00 while maintaining a Buy rating.

Dynatrace (DT) — Rosenblatt Securities lowered its price target for the stock from $70.00 to $65.00 while maintaining a Buy rating.

Dynatrace (DT) — Royal Bank Of Canada lowered its price target for the stock from $73.00 to $68.00 while maintaining an Outperform rating.

Dynatrace (DT) — UBS Group lowered its price target for the stock from $80.00 to $75.00 while maintaining a Buy rating.

Dynatrace (DT) — Wedbush lowered its price target for the stock from $54.00 to $50.00 while maintaining a Neutral rating.

Dynatrace (DT) — Wells Fargo & Company lowered its price target for the stock from $75.00 to $65.00 while maintaining an Overweight rating.

Eastman Chemical (EMN) — Royal Bank Of Canada raised its price target for the stock from $65.00 to $70.00 while maintaining a Sector Perform rating.

Eaton (ETN) — Mizuho set a price target of $485.00.

Eaton (ETN) — Royal Bank Of Canada raised its price target for the stock from $526.00 to $539.00 while maintaining an Outperform rating.

Eaton (ETN) — Wells Fargo & Company lowered its price target for the stock from $503.00 to $485.00 while maintaining an Overweight rating.

Echostar (ECHO) — Morgan Stanley lowered its price target for the stock from $134.00 to $132.00 while maintaining an Overweight rating.

Echostar (ECHO) — UBS Group raised its price target for the stock from $150.00 to $160.00 while maintaining a Buy rating.

Edwards Lifesciences (EW) — Truist Financial set a price target of $95.00 to $113.00 with a Hold to Buy rating.

EMCOR Group (EME) — UBS Group lowered its price target for the stock from $1,065.00 to $925.00 while maintaining a Buy rating.

Enpro (NPO) — JPMorgan Chase & Co. raised its price target for the stock from $430.00 to $440.00 while maintaining an Overweight rating.

EPAM Systems (EPAM) — Morgan Stanley raised its price target for the stock from $97.00 to $140.00 while maintaining an Equal Weight rating.

Equitable (EQH) — Truist Financial raised its price target for the stock from $60.00 to $65.00 while maintaining a Buy rating.

Estee Lauder Companies (EL) — Barclays raised its price target for the stock from $108.00 to $126.00 while maintaining an Overweight rating.

Everest Group (EG) — Keefe, Bruyette & Woods raised its price target for the stock from $407.00 to $450.00 while maintaining an Outperform rating.

Evertec (EVTC) — Keefe, Bruyette & Woods raised its price target for the stock from $38.00 to $42.00 while maintaining an Outperform rating.

Expeditors International of Washington (EXPD) — Barclays raised its price target for the stock from $165.00 to $175.00 while maintaining an Underweight rating.

Expeditors International of Washington (EXPD) — JPMorgan Chase & Co. raised its price target for the stock from $214.00 to $220.00 while maintaining a Neutral rating.

Expeditors International of Washington (EXPD) — Truist Financial raised its price target for the stock from $175.00 to $200.00 while maintaining a Hold rating.

Expeditors International of Washington (EXPD) — UBS Group raised its price target for the stock from $220.00 to $245.00 while maintaining a Buy rating.

Expro Group (XPRO) — Piper Sandler lowered its price target for the stock from $16.00 to $15.00 while maintaining an Underweight rating.

Extra Space Storage (EXR) — UBS Group raised its price target for the stock from $152.00 to $174.00 while maintaining a Buy rating.

ExxonMobil (XOM) — Citigroup raised its price target for the stock from $155.00 to $175.00 while maintaining a Neutral rating.

ExxonMobil (XOM) — DZ Bank downgraded the stock from Hold to Sell, with a price target of $170.00.

ExxonMobil (XOM) — TD Cowen raised its price target for the stock from $180.00 to $193.00 while maintaining a Buy rating.

Fabrinet (FN) — Barclays lowered its price target for the stock from $739.00 to $496.00 while maintaining an Overweight rating.

Ferrovial (FER) — Citigroup upgraded the stock from Neutral to Buy.

Fidelity National Information Services (FIS) — JPMorgan Chase & Co. downgraded the stock from Overweight to Neutral, with a price target of $38.00.

Fidelity National Information Services (FIS) — Oppenheimer downgraded the stock from Outperform to Market Perform.

Fidelity National Information Services (FIS) — Raymond James Financial reiterated its Outperform rating, with a price target of $35.00.

Fidelity National Information Services (FIS) — William Blair downgraded the stock from Outperform to Market Perform.

Firefly Aerospace (FLY) — B. Riley Financial lowered its price target for the stock from $50.00 to $40.00 while maintaining a Buy rating.

First Watch Restaurant Group (FWRG) — Stephens reiterated its Overweight rating, with a price target of $18.00.

Fiserv (FISV) — Argus upgraded the stock from Hold to Buy, with a price target of $72.00.

Fiserv (FISV) — B. Riley Financial reiterated its Neutral rating, and revised its price target from $51.00 to $60.00.

Fiserv (FISV) — Barclays raised its price target for the stock from $50.00 to $59.00 while maintaining an Equal Weight rating.

Fiserv (FISV) — Citigroup raised its price target for the stock from $53.00 to $62.00 while maintaining a Neutral rating.

Fiserv (FISV) — JPMorgan Chase & Co. raised its price target for the stock from $60.00 to $65.00 while maintaining a Neutral rating.

Fiserv (FISV) — Keefe, Bruyette & Woods raised its price target for the stock from $60.00 to $70.00 while maintaining an Outperform rating.

Fiserv (FISV) — Morgan Stanley raised its price target for the stock from $59.00 to $61.00 while maintaining an Equal Weight rating.

Fiserv (FISV) — Royal Bank Of Canada raised its price target for the stock from $65.00 to $70.00 while maintaining an Outperform rating.

Fiserv (FISV) — TD Cowen raised its price target for the stock from $49.00 to $59.00 while maintaining a Hold rating.

Fiserv (FISV) — UBS Group raised its price target for the stock from $60.00 to $68.00 while maintaining a Neutral rating.

Flagstar Bank, National Association (FLG) — Morgan Stanley downgraded the stock from Overweight to Underweight, adjusting its price target from $15.00 to $12.00.

Flutter Entertainment (FLUT) — BTIG Research raised its price target for the stock from $95.00 to $96.00 while maintaining a Buy rating.

Flutter Entertainment (FLUT) — Jefferies Financial Group reiterated its Buy rating, with a price target of $160.00.

Flutter Entertainment (FLUT) — Stifel Nicolaus set a price target of $124.00.

Flux Power Holdings (FLUX) — Lake Street downgraded the stock from Buy to Hold, with a price target of $1.

Flywire (FLYW) — B. Riley Financial reiterated its Buy rating, and revised its price target from $24.00 to $25.00.

Flywire (FLYW) — BTIG Research raised its price target for the stock from $20.00 to $22.00 while maintaining a Buy rating.

Flywire (FLYW) — JPMorgan Chase & Co. raised its price target for the stock from $20.00 to $23.00 while maintaining a Neutral rating.

Flywire (FLYW) — Morgan Stanley raised its price target for the stock from $24.00 to $26.00 while maintaining an Overweight rating.

Flywire (FLYW) — Raymond James Financial reiterated its Outperform rating, with a price target of $24.00.

Flywire (FLYW) — UBS Group raised its price target for the stock from $19.00 to $21.50 while maintaining a Neutral rating.

Fortinet (FTNT) — Daiwa Securities Group upgraded the stock from Neutral to Outperform, with a price target of $150.00.

Fortune Brands Innovations (FBIN) — Barclays lowered its price target for the stock from $47.00 to $40.00 while maintaining an Equal Weight rating.

Fortune Brands Innovations (FBIN) — DA Davidson set a price target of $58.00.

Fortune Brands Innovations (FBIN) — Royal Bank Of Canada lowered its price target for the stock from $49.00 to $48.00 while maintaining an Outperform rating.

Fortune Brands Innovations (FBIN) — Truist Financial lowered its price target for the stock from $70.00 to $60.00 while maintaining a Buy rating.

Fortune Brands Innovations (FBIN) — Wells Fargo & Company raised its price target for the stock from $48.00 to $51.00 while maintaining an Overweight rating.

Freshworks (FRSH) — Canaccord Genuity Group raised its price target for the stock from $15.00 to $17.00 while maintaining a Buy rating.

Freshworks (FRSH) — Cantor Fitzgerald raised its price target for the stock from $15.00 to $20.00 while maintaining an Overweight rating.

Freshworks (FRSH) — Needham & Company LLC reiterated its Buy rating, with a price target of $15.00.

Freshworks (FRSH) — Oppenheimer reiterated its Market Perform rating.

Freshworks (FRSH) — Piper Sandler raised its price target for the stock from $12.00 to $15.00 while maintaining a Neutral rating.

Freshworks (FRSH) — UBS Group raised its price target for the stock from $14.00 to $17.00 while maintaining a Buy rating.

Freshworks (FRSH) — Wolfe Research downgraded the stock from Outperform to Peer Perform.

Gaming and Leisure Properties (GLPI) — Cantor Fitzgerald lowered its price target for the stock from $48.00 to $42.00 while maintaining a Neutral rating.

Gaming and Leisure Properties (GLPI) — Citigroup lowered its price target for the stock from $59.00 to $49.00 while maintaining a Buy rating.

Gartner (IT) — BMO Capital Markets reiterated its Market Perform rating, with a price target of $231.00.

Gartner (IT) — Morgan Stanley raised its price target for the stock from $182.00 to $192.00 while maintaining an Equal Weight rating.

Gartner (IT) — The Goldman Sachs Group raised its price target for the stock from $181.00 to $207.00 while maintaining a Neutral rating.

Gartner (IT) — Truist Financial downgraded the stock from Buy to Hold, adjusting its price target from $235.00 to $210.00.

Gartner (IT) — UBS Group raised its price target for the stock from $208.00 to $220.00 while maintaining a Neutral rating.

Gilead Sciences (GILD) — Jefferies Financial Group set a price target of $196.00.

Gladstone Commercial (GOOD) — B. Riley Financial reiterated its Neutral rating, and revised its price target from $12.50 to $11.50.

GlobalFoundries (GFS) — Jefferies Financial Group reiterated its Hold rating, with a price target of $50.00.

GlobalFoundries (GFS) — Needham & Company LLC lowered its price target for the stock from $80.00 to $55.00 while maintaining a Buy rating.

Graphic Packaging (GPK) — JPMorgan Chase & Co. raised its price target for the stock from $11.50 to $12.00 while maintaining an Overweight rating.

Graphic Packaging (GPK) — Raymond James Financial reiterated coverage.

Graphic Packaging (GPK) — Royal Bank Of Canada raised its price target for the stock from $9.00 to $12.00 while maintaining a Sector Perform rating.

Graphic Packaging (GPK) — Truist Financial reiterated its Hold rating, and revised its price target from $9.00 to $10.00.

Graphic Packaging (GPK) — Truist Financial set a price target of $9.00.

Graphic Packaging (GPK) — UBS Group raised its price target for the stock from $9.50 to $11.50 while maintaining a Neutral rating.

Group 1 Automotive (GPI) — Jefferies Financial Group set a price target of $250.00.

Group 1 Automotive (GPI) — JPMorgan Chase & Co. downgraded the stock from Neutral to Underweight, adjusting its price target from $255.00 to $250.00.

Grupo Televisa (TV) — UBS Group lowered its price target for the stock from $3.20 to $2.30 while maintaining a Neutral rating.

GXO Logistics (GXO) — Susquehanna set a price target of $72.00.

GXO Logistics (GXO) — TD Cowen reiterated its Buy rating.

Hagerty (HGTY) — Citizens Jmp raised its price target for the stock from $15.00 to $19.00 while maintaining a Market Outperform rating.

Hagerty (HGTY) — Truist Financial raised its price target for the stock from $13.00 to $16.00 while maintaining a Hold rating.

Hagerty (HGTY) — Wells Fargo & Company raised its price target for the stock from $14.00 to $17.00 while maintaining an Equal Weight rating.

Haleon (HLN) — Jefferies Financial Group downgraded the stock from Buy to Hold.

Hamilton Insurance Group (HG) — Keefe, Bruyette & Woods raised its price target for the stock from $40.00 to $42.00 while maintaining an Outperform rating.

Hamilton Lane (HLNE) — JPMorgan Chase & Co. lowered its price target for the stock from $150.00 to $144.00 while maintaining an Overweight rating.

Hamilton Lane (HLNE) — Keefe, Bruyette & Woods raised its price target for the stock from $116.00 to $120.00 while maintaining an Outperform rating.

Hamilton Lane (HLNE) — Wells Fargo & Company raised its price target for the stock from $103.00 to $114.00 while maintaining an Overweight rating.

Healthpeak Properties (DOC) — Cantor Fitzgerald lowered its price target for the stock from $23.00 to $21.00 while maintaining a Neutral rating.

HealthStream (HSTM) — Canaccord Genuity Group raised its price target for the stock from $29.00 to $32.00 while maintaining a Hold rating.

Hecla Mining (HL) — Scotiabank lowered its price target for the stock from $21.00 to $20.00 while maintaining a Sector Perform rating.

Henry Schein (HSIC) — UBS Group raised its price target for the stock from $94.00 to $95.00 while maintaining a Neutral rating.

Hess Midstream Partners (HESM) — Wells Fargo & Company lowered its price target for the stock from $40.00 to $34.00 while maintaining an Equal Weight rating.

Hillman Solutions (HLMN) — Canaccord Genuity Group lowered its price target for the stock from $13.00 to $12.00 while maintaining a Buy rating.

Huntsman (HUN) — Barclays raised its price target for the stock from $10.00 to $11.00 while maintaining an Equal Weight rating.

Huntsman (HUN) — Citigroup raised its price target for the stock from $9.00 to $10.00 while maintaining a Neutral rating.

Huntsman (HUN) — Royal Bank Of Canada raised its price target for the stock from $9.00 to $10.00 while maintaining a Sector Perform rating.

Huntsman (HUN) — UBS Group raised its price target for the stock from $9.00 to $10.00 while maintaining a Neutral rating.

Huron Consulting Group (HURN) — Wedbush raised its price target for the stock from $160.00 to $220.00 while maintaining an Outperform rating.

Ibotta (IBTA) — Citigroup raised its price target for the stock from $34.00 to $60.00 while maintaining a Neutral rating.

IDEAYA Biosciences (IDYA) — Guggenheim lowered its price target for the stock from $57.00 to $52.00 while maintaining a Buy rating.

IDEAYA Biosciences (IDYA) — Royal Bank Of Canada lowered its price target for the stock from $48.00 to $45.00 while maintaining an Outperform rating.

IDEAYA Biosciences (IDYA) — Wedbush raised its price target for the stock from $60.00 to $63.00 while maintaining an Outperform rating.

Innovative Industrial Properties (IIPR) — Piper Sandler raised its price target for the stock from $44.00 to $46.00 while maintaining an Underweight rating.

Insmed (INSM) — HC Wainwright resumed coverage with a Buy rating and a $220.00 price target.

Insulet (PODD) — Jefferies Financial Group reiterated its Buy rating, with a price target of $200.00.

Insulet (PODD) — TD Cowen reiterated its Hold rating.

Intuitive Machines (LUNR) — B. Riley Financial lowered its price target for the stock from $43.00 to $34.00 while maintaining a Buy rating.

IPG Photonics (IPGP) — Needham & Company LLC lowered its price target for the stock from $43.00 to $50.00 while maintaining a Neutral to Overweight rating.

Isabella Bank Corporation (ISBA) — Piper Sandler upgraded the stock from Neutral to Overweight, with a price target of $50.

Jackson Financial (JXN) — Barclays raised its price target for the stock to $42.00 while maintaining a Buy rating.

Janus Living (JAN) — Cantor Fitzgerald lowered its price target for the stock from $34.00 to $33.00 while maintaining an Overweight rating.

JFrog (FROG) — Cantor Fitzgerald reiterated its Overweight rating, with a price target of $115.00.

Kardigan (KARD) — H.C. Wainwright initiated coverage with a Buy rating and a $42 price target.

Keurig Dr Pepper (KDP) — Citigroup raised its price target for the stock from $37.00 to $40.00 while maintaining a Buy rating.

Keurig Dr Pepper (KDP) — JPMorgan Chase & Co. raised its price target for the stock from $39.00 to $41.00 while maintaining an Overweight rating.

Keurig Dr Pepper (KDP) — Morgan Stanley raised its price target for the stock from $38.00 to $40.00 while maintaining an Overweight rating.

Keurig Dr Pepper (KDP) — TD Cowen raised its price target for the stock from $33.00 to $35.00 while maintaining a Hold rating.

Keurig Dr Pepper (KDP) — UBS Group raised its price target for the stock from $39.00 to $42.00 while maintaining a Buy rating.

Keurig Dr Pepper (KDP) — Wells Fargo & Company raised its price target for the stock from $37.00 to $40.00 while maintaining an Overweight rating.

Kraft Heinz (KHC) — Jefferies Financial Group reiterated its Hold rating, with a price target of $24.00.

Largo (LGO) — HC Wainwright lowered its price target for the stock from $33.00 to $61.00 while maintaining a Buy rating.

Leidos (LDOS) — Guggenheim reiterated its Buy rating, with a price target of $160.00.

LendingTree (TREE) — JPMorgan Chase & Co. lowered its price target for the stock from $48.00 to $40.00 while maintaining an Overweight rating.

LendingTree (TREE) — Truist Financial lowered its price target for the stock from $70.00 to $65.00 while maintaining a Buy rating.

Lindblad Expeditions (LIND) — Stifel Nicolaus set a price target of $43.00.

LivaNova (LIVN) — Jefferies Financial Group reiterated its Buy rating.

LivaNova (LIVN) — Mizuho set a price target of $115.00.

LivaNova (LIVN) — Needham & Company LLC raised its price target for the stock from $93.00 to $112.00 while maintaining a Buy rating.

LivaNova (LIVN) — Raymond James Financial set a price target of $120.00.

Lockheed Martin (LMT) — Guggenheim initiated coverage with a Buy rating and a $735.00 price target.

Louisiana-Pacific (LPX) — Barclays lowered its price target for the stock from $88.00 to $86.00 while maintaining an Overweight rating.

Louisiana-Pacific (LPX) — Jefferies Financial Group reiterated its Buy rating, with a price target of $90.00.

Louisiana-Pacific (LPX) — Royal Bank Of Canada raised its price target for the stock from $84.00 to $85.00 while maintaining an Outperform rating.

Louisiana-Pacific (LPX) — Truist Financial reiterated its Buy rating, and revised its price target from $89.00 to $84.00.

Madrigal Pharmaceuticals (MDGL) — Canaccord Genuity Group raised its price target for the stock from $612.00 to $633.00 while maintaining a Buy rating.

Madrigal Pharmaceuticals (MDGL) — Truist Financial reiterated its Buy rating, and revised its price target from $709.00 to $743.00.

Marathon Petroleum (MPC) — Morgan Stanley raised its price target for the stock from $453.00 to $458.00 while maintaining an Overweight rating.

Marathon Petroleum (MPC) — Wells Fargo & Company raised its price target for the stock from $560.00 to $564.00 while maintaining an Overweight rating.

Marqeta (MQ) — Susquehanna reiterated its Outperform rating.

Marriott International (MAR) — Jefferies Financial Group reiterated its Buy rating.

Marriott International (MAR) — Sanford C. Bernstein reiterated its Outperform rating, with a price target of $445.00.

Marzetti (MZTI) — Stephens reiterated its Equal Weight rating, with a price target of $135.00.

MasTec (MTZ) — Jefferies Financial Group reiterated its Buy rating, with a price target of $353.00.

McDonald’s (MCD) — TD Cowen raised its price target for the stock from $270.00 to $285.00 while maintaining a Hold rating.

Metallus (MTUS) — KeyCorp reiterated coverage.

MiNK Therapeutics (INKT) — HC Wainwright resumed coverage with a Buy rating and a $38.00 price target.

Mirum Pharmaceuticals (MIRM) — Cantor Fitzgerald raised its price target for the stock from $155.00 to $160.00 while maintaining an Overweight rating.

Mirum Pharmaceuticals (MIRM) — Citizens Jmp raised its price target for the stock from $144.00 to $167.00 while maintaining a Market Outperform rating.

Mirum Pharmaceuticals (MIRM) — HC Wainwright raised its price target for the stock from $200.00 to $202.00 while maintaining a Buy rating.

Mirum Pharmaceuticals (MIRM) — Raymond James Financial reiterated its Strong-Buy rating, with a price target of $189.00.

Mirum Pharmaceuticals (MIRM) — Royal Bank Of Canada reiterated its Outperform rating, with a price target of $155.00.

Modine Manufacturing (MOD) — KeyCorp lowered its price target for the stock from $280.00 to $225.00 while maintaining an Overweight rating.

Mosaic (MOS) — Mizuho set a price target of $20.00.

MSG Knickerbockers Corp (MSGK) — Wolfe Research upgraded the stock from Peer Perform to Outperform.

MSG Rangers Corp (MSGR) — Wolfe Research initiated coverage with an Outperform rating.

Mvb Financial (MVBF) — Keefe, Bruyette & Woods lowered its price target for the stock from $34.00 to $31.00 while maintaining an Outperform rating.

Nabors Industries (NBR) — Citigroup lowered its price target for the stock from $110.00 to $100.00 while maintaining a Neutral rating.

Navitas Semiconductor (NVTS) — Craig Hallum upgraded the stock from Hold to Buy, with a price target of $13.00.

Navitas Semiconductor (NVTS) — Needham & Company LLC lowered its price target for the stock from $21.00 to $15.00 while maintaining a Buy rating.

Navitas Semiconductor (NVTS) — Rosenblatt Securities upgraded the stock from Neutral to Buy, with a price target of $13.00.

Nebius Group (NBIS) — Citigroup lowered its price target for the stock from $324.00 to $265.00 while maintaining a Buy rating.

Neostellar Capital (NSLR) — BTIG Research lowered its price target for the stock from $14.00 to $13.00 while maintaining a Buy rating.

Netskope (NTSK) — Cantor Fitzgerald initiated coverage with an Overweight rating and a $28.00 price target.

Neurocrine Biosciences (NBIX) — Guggenheim raised its price target for the stock from $207.00 to $224.00 while maintaining a Buy rating.

Neutron (LIME) — Citizens Jmp lowered its price target for the stock from $33.00 to $27.00 while maintaining a Market Outperform rating.

Neutron (LIME) — Evercore reiterated its Outperform rating, with a price target of $35.00.

Neutron (LIME) — JPMorgan Chase & Co. lowered its price target for the stock from $38.00 to $33.00 while maintaining an Overweight rating.

Neutron (LIME) — Needham & Company LLC lowered its price target for the stock from $36.00 to $29.00 while maintaining a Buy rating.

Neutron (LIME) — The Goldman Sachs Group reiterated its Buy rating, with a price target of $37.00.

Neutron (LIME) — UBS Group reiterated its Buy rating.

New Mountain Finance (NMFC) — Bank of America reiterated coverage.

New Mountain Finance (NMFC) — Wells Fargo & Company lowered its price target for the stock from $7.50 to $7.00 while maintaining an Equal Weight rating.

Nomad Foods (NOMD) — Jefferies Financial Group reiterated its Buy rating, with a price target of $15.00.

Nucor (NUE) — Cfra upgraded the stock from Strong Sell to Hold.

Nucor (NUE) — KeyCorp raised its price target for the stock from $286.00 to $301.00 while maintaining an Overweight rating.

Nurix Therapeutics (NRIX) — Wells Fargo & Company lowered its price target for the stock from $25.00 to $20.00 while maintaining an Overweight rating.

Nuveen Churchill Direct Lending (NCDL) — Keefe, Bruyette & Woods lowered its price target for the stock from $13.50 to $13.00 while maintaining a Market Perform rating.

Nuveen Churchill Direct Lending (NCDL) — Wells Fargo & Company reiterated its Underweight rating, with a price target of $11.00.

Oculis (OCS) — Guggenheim lowered its price target for the stock to $40.00 while maintaining a Buy rating.

ON (ONON) — Wells Fargo & Company initiated coverage with an Overweight rating and a $48.00 price target.

ONE Gas (OGS) — BTIG Research reiterated its Buy rating, with a price target of $95.00.

ONE Gas (OGS) — Scotiabank raised its price target for the stock from $86.00 to $87.00 while maintaining a Sector Outperform rating.

ONE Gas (OGS) — Wells Fargo & Company raised its price target for the stock from $85.00 to $86.00 while maintaining an Equal Weight rating.

OneMain (OMF) — Wells Fargo & Company lowered its price target for the stock from $65.00 to $62.00 while maintaining an Equal Weight rating.

ONEOK (OKE) — Argus set a price target of $108.00.

onsemi (ON) — Citigroup lowered its price target for the stock from $98.00 to $80.00 while maintaining a Neutral rating.

Oportun Financial (OPRT) — Stephens raised its price target for the stock from $12.00 to $14.00 while maintaining an Overweight rating.

Otter Tail (OTTR) — Siebert Williams Shank upgraded the stock from Hold to Buy, with a price target of $91.00.

Ouster (OUST) — Cantor Fitzgerald upgraded the stock from Neutral to Overweight, with a price target of $45.00.

Ouster (OUST) — Oppenheimer reiterated its Outperform rating.

Ouster (OUST) — Rosenblatt Securities reiterated its Buy rating, with a price target of $53.00.

Ovintiv (OVV) — Barclays raised its price target for the stock from $75.00 to $80.00 while maintaining an Overweight rating.

Palantir Technologies (PLTR) — Barclays raised its price target for the stock from $265.00 to $273.00 while maintaining an Overweight rating.

Palantir Technologies (PLTR) — KeyCorp reiterated coverage.

Palantir Technologies (PLTR) — Raymond James Financial set a price target of $255.00.

Penguin Solutions (PENG) — Rosenblatt Securities reiterated its Buy rating, with a price target of $100.00.

PennyMac Mortgage Investment Trust (PMT) — Wells Fargo & Company lowered its price target for the stock from $10.00 to $9.00 while maintaining an Equal Weight rating.

People Incorporated Common Stock (PPLI) — Citigroup lowered its price target for the stock from $52.00 to $47.00 while maintaining a Buy rating.

People Incorporated Common Stock (PPLI) — Citizens Jmp lowered its price target for the stock from $54.00 to $47.00 while maintaining a Market Outperform rating.

People Incorporated Common Stock (PPLI) — KeyCorp lowered its price target for the stock from $50.00 to $44.00 while maintaining an Overweight rating.

People Incorporated Common Stock (PPLI) — TD Cowen lowered its price target for the stock from $70.00 to $60.00 while maintaining a Buy rating.

People Incorporated Common Stock (PPLI) — The Goldman Sachs Group lowered its price target for the stock from $63.00 to $56.00 while maintaining a Buy rating.

People Incorporated Common Stock (PPLI) — Truist Financial lowered its price target for the stock from $62.00 to $59.00 while maintaining a Buy rating.

Performance Food Group (PFGC) — TD Cowen raised its price target for the stock from $110.00 to $125.00 while maintaining a Buy rating.

Pershing Square (PS) — Royal Bank Of Canada raised its price target for the stock from $44.00 to $45.00 while maintaining a Sector Perform rating.

Pfizer (PFE) — Argus set a price target of $40.00.

Pfizer (PFE) — Citigroup raised its price target for the stock from $27.00 to $30.00 while maintaining a Neutral rating.

Pfizer (PFE) — Royal Bank Of Canada raised its price target for the stock from $25.00 to $28.00 while maintaining a Sector Perform rating.

Pfizer (PFE) — Scotiabank raised its price target for the stock from $33.00 to $35.00 while maintaining a Sector Outperform rating.

Pfizer (PFE) — UBS Group raised its price target for the stock from $27.00 to $30.00 while maintaining a Neutral rating.

Phillips 66 (PSX) — Citigroup raised its price target for the stock from $297.00 to $302.00 while maintaining a Neutral rating.

Phoenix Education Partners (PXED) — B. Riley Financial downgraded the stock from Buy to Neutral, adjusting its price target from $44.00 to $25.00.

Phoenix Education Partners (PXED) — Barrington Research downgraded the stock from Outperform to Market Perform.

Phoenix Education Partners (PXED) — Morgan Stanley downgraded the stock from Overweight to Equal Weight, with a price target of $28.00.

Phoenix Education Partners (PXED) — Truist Financial lowered its price target for the stock from $38.00 to $23.00 while maintaining a Hold rating.

PJT Partners (PJT) — Keefe, Bruyette & Woods lowered its price target for the stock from $159.00 to $155.00 while maintaining a Market Perform rating.

Primo Brands (PRMB) — Royal Bank Of Canada reiterated its Outperform rating.

Procore Technologies (PCOR) — JPMorgan Chase & Co. raised its price target for the stock from $69.00 to $74.00 while maintaining an Overweight rating.

Procore Technologies (PCOR) — Mizuho set a price target of $68.00.

ProPetro (PUMP) — Citigroup lowered its price target for the stock from $14.50 to $12.00 while maintaining a Buy rating.

Prudential Financial (PRU) — Bank of America reiterated its Neutral rating.

Prudential Financial (PRU) — Barclays raised its price target for the stock from $94.00 to $98.00 while maintaining an Underweight rating.

Public Storage (PSA) — UBS Group raised its price target for the stock from $294.00 to $334.00 while maintaining a Neutral rating.

Ramaco Resources (METC) — B. Riley Financial lowered its price target for the stock from $24.00 to $17.00 while maintaining a Buy rating.

Ramaco Resources (METC) — The Goldman Sachs Group lowered its price target for the stock from $8.00 to $7.00 while maintaining a Neutral rating.

Rapport Therapeutics (RAPP) — Raymond James Financial set a price target of $73.00.

Red Rock Resorts (RRR) — Citizens Jmp lowered its price target for the stock from $71.00 to $70.00 while maintaining a Market Outperform rating.

Red Rock Resorts (RRR) — JPMorgan Chase & Co. lowered its price target for the stock from $71.00 to $64.00 while maintaining an Overweight rating.

Red Rock Resorts (RRR) — Mizuho set a price target of $62.00.

Red Rock Resorts (RRR) — Susquehanna reiterated its Positive rating, with a price target of $64.00.

Redwood Trust (RWT) — Wells Fargo & Company lowered its price target for the stock from $6.00 to $3.50 while maintaining an Equal Weight rating.

Regal Rexnord (RRX) — Citigroup raised its price target for the stock from $200.00 to $210.00 while maintaining a Buy rating.

Revolve Group (RVLV) — Morgan Stanley set a price target of $25.00.

Revolve Group (RVLV) — Piper Sandler lowered its price target for the stock from $30.00 to $26.00 while maintaining an Overweight rating.

Revolve Group (RVLV) — Stifel Nicolaus set a price target of $31.00.

Revolve Group (RVLV) — TD Cowen lowered its price target for the stock from $31.00 to $25.00 while maintaining a Buy rating.

Revolve Group (RVLV) — UBS Group lowered its price target for the stock from $27.00 to $26.00 while maintaining a Neutral rating.

Revvity (RVTY) — Bank of America reiterated its Neutral rating.

Revvity (RVTY) — Barclays raised its price target for the stock from $160.00 to $175.00 while maintaining an Equal Weight rating.

Revvity (RVTY) — Cfra upgraded the stock from Hold to Buy.

Revvity (RVTY) — JPMorgan Chase & Co. raised its price target for the stock from $155.00 to $160.00 while maintaining a Neutral rating.

Revvity (RVTY) — Royal Bank Of Canada raised its price target for the stock from $135.00 to $172.00 while maintaining a Sector Perform rating.

Revvity (RVTY) — TD Cowen raised its price target for the stock from $175.00 to $185.00 while maintaining a Buy rating.

Rhythm Pharmaceuticals (RYTM) — Citizens Jmp raised its price target for the stock from $160.00 to $166.00 while maintaining a Market Outperform rating.

Rhythm Pharmaceuticals (RYTM) — Oppenheimer reiterated its Market Perform rating.

Rhythm Pharmaceuticals (RYTM) — Royal Bank Of Canada reiterated its Outperform rating.

RXO (RXO) — UBS Group raised its price target for the stock from $23.00 to $30.25 while maintaining a Neutral rating.

RxSight (RXST) — Needham & Company LLC lowered its price target for the stock from $11.00 to $7.00 while maintaining a Buy rating.

RxSight (RXST) — Piper Sandler lowered its price target for the stock from $10.00 to $8.00 while maintaining a Neutral rating.

RxSight (RXST) — Wells Fargo & Company lowered its price target for the stock from $9.00 to $6.00 while maintaining an Equal Weight rating.

Safehold (SAFE) — Royal Bank Of Canada lowered its price target for the stock from $13.00 to $12.00 while maintaining a Sector Perform rating.

SBA Communications (SBAC) — Truist Financial lowered its price target for the stock from $238.00 to $235.00 while maintaining a Buy rating.

Sensei Biotherapeutics (FTH) — Guggenheim lowered its price target for the stock from $70.00 to $69.00 while maintaining a Buy rating.

Septerna (SEPN) — Wells Fargo & Company raised its price target for the stock from $50.00 to $61.00 while maintaining an Overweight rating.

SharkNinja (SN) — Jefferies Financial Group reiterated its Buy rating, with a price target of $300.00.

SharkNinja (SN) — William Blair reiterated its Outperform rating.

Shopify (SHOP) — Cantor Fitzgerald lowered its price target for the stock from $158.00 to $150.00 while maintaining a Neutral rating.

Shopify (SHOP) — National Bank Financial raised its price target for the stock from $180.00 to $185.00 while maintaining an Outperform rating.

Shopify (SHOP) — Needham & Company LLC reiterated its Buy rating.

Shopify (SHOP) — Rosenblatt Securities lowered its price target for the stock from $186.00 to $180.00 while maintaining a Buy rating.

Shopify (SHOP) — Royal Bank Of Canada reiterated its Outperform rating, with a price target of $200.00.

Shopify (SHOP) — Sanford C. Bernstein reiterated its Outperform rating, with a price target of $165.00.

Shopify (SHOP) — UBS Group raised its price target for the stock from $145.00 to $160.00 while maintaining a Neutral rating.

Shopify (SHOP) — Wedbush reiterated its Outperform rating, with a price target of $176.00.

Shopify (SHOP) — Wells Fargo & Company reiterated its Overweight rating, and revised its price target from $208.00 to $205.00.

Silver Standard Resources (SSRM) — UBS Group lowered its price target for the stock from $39.00 to $37.00 while maintaining a Buy rating.

Skyworks Solutions (SWKS) — Bank of America lowered its price target for the stock from $78.00 to $72.00 while maintaining an Underperform rating.

Skyworks Solutions (SWKS) — Citigroup lowered its price target for the stock from $90.00 to $79.00 while maintaining a Neutral rating.

Skyworks Solutions (SWKS) — Jefferies Financial Group downgraded the stock to Buy.

Skyworks Solutions (SWKS) — Mizuho set a price target of $58.00.

Skyworks Solutions (SWKS) — Morgan Stanley set a price target of $93.00.

Skyworks Solutions (SWKS) — Royal Bank Of Canada lowered its price target for the stock from $95.00 to $80.00 while maintaining a Sector Perform rating.

Skyworks Solutions (SWKS) — Susquehanna lowered its price target for the stock from $90.00 to $75.00 while maintaining a Neutral rating.

Skyworks Solutions (SWKS) — The Goldman Sachs Group resumed coverage with a Sell rating and a $78.00 price target.

Sonic Automotive (SAH) — Barclays lowered its price target for the stock from $75.00 to $73.00 while maintaining an Equal Weight rating.

Sonic Automotive (SAH) — JPMorgan Chase & Co. lowered its price target for the stock from $63.00 to $58.00 while maintaining an Underweight rating.

Sotera Health (SHC) — Barclays lowered its price target for the stock from $22.00 to $20.00 while maintaining an Overweight rating.

Sotera Health (SHC) — JPMorgan Chase & Co. lowered its price target for the stock from $17.00 to $15.00 while maintaining an Underweight rating.

Sportradar Group (SRAD) — Citizens Jmp lowered its price target for the stock from $20.00 to $19.00 while maintaining a Market Outperform rating.

Sportradar Group (SRAD) — Guggenheim lowered its price target for the stock from $26.00 to $23.00 while maintaining a Buy rating.

Sportradar Group (SRAD) — JPMorgan Chase & Co. lowered its price target for the stock from $13.00 to $12.00 while maintaining a Neutral rating.

Sportradar Group (SRAD) — Needham & Company LLC raised its price target for the stock from $17.00 to $20.00 while maintaining a Buy rating.

Sportradar Group (SRAD) — Truist Financial raised its price target for the stock from $16.00 to $17.00 while maintaining a Buy rating.

Sprout Social (SPT) — Canaccord Genuity Group raised its price target for the stock from $10.00 to $13.50 while maintaining a Hold rating.

Sprout Social (SPT) — Cantor Fitzgerald raised its price target for the stock from $8.00 to $13.00 while maintaining a Neutral rating.

Sprout Social (SPT) — KeyCorp raised its price target for the stock from $7.00 to $10.00 while maintaining an Underweight rating.

Sprout Social (SPT) — Needham & Company LLC reiterated its Buy rating, with a price target of $14.00.

Spyre Therapeutics (SYRE) — Guggenheim raised its price target for the stock from $130.00 to $135.00 while maintaining a Buy rating.

Spyre Therapeutics (SYRE) — Wedbush lowered its price target for the stock from $123.00 to $120.00 while maintaining an Outperform rating.

Starwood Property Trust (STWD) — Keefe, Bruyette & Woods lowered its price target for the stock from $16.00 to $15.00 while maintaining an Outperform rating.

Stevanato Group (STVN) — Citigroup lowered its price target for the stock from $26.00 to $20.00 while maintaining a Buy rating.

Stevanato Group (STVN) — UBS Group lowered its price target for the stock from $23.00 to $16.00 while maintaining a Neutral rating.

Stevanato Group (STVN) — William Blair downgraded the stock from Outperform to Market Perform.

Sunoco (SUN) — Wells Fargo & Company raised its price target for the stock from $82.00 to $85.00 while maintaining an Overweight rating.

Super Group (SGHC) (SGHC) — BTIG Research lowered its price target for the stock from $19.00 to $16.00 while maintaining a Buy rating.

Super Micro Computer (SMCI) — Bank of America raised its price target for the stock from $38.00 to $39.00 while maintaining an Underperform rating.

Super Micro Computer (SMCI) — Oppenheimer upgraded the stock to Outperform.

Super Micro Computer (SMCI) — Raymond James Financial reiterated its Outperform rating, with a price target of $65.00.

Super Micro Computer (SMCI) — Rosenblatt Securities reiterated its Buy rating, with a price target of $57.00.

Supernus Pharmaceuticals (SUPN) — Cantor Fitzgerald raised its price target for the stock from $67.00 to $87.00 while maintaining an Overweight rating.

Supernus Pharmaceuticals (SUPN) — Piper Sandler resumed coverage with an Overweight rating and a $47.00 price target.

Sysco (SYY) — JPMorgan Chase & Co. lowered its price target for the stock from $95.00 to $92.00.

Sysco (SYY) — Sanford C. Bernstein reiterated its Market Perform rating.

Take-Two Interactive Software (TTWO) — BTIG Research lowered its price target for the stock from $313.00 to $262.00 while maintaining a Buy rating.

Tarsus Pharmaceuticals (TARS) — HC Wainwright raised its price target for the stock from $88.00 to $106.00 while maintaining a Buy rating.

Teladoc Health (TDOC) — Barclays raised its price target for the stock from $7.00 to $9.00 while maintaining an Equal Weight rating.

Telesat (TSAT) — Desjardins initiated coverage with a Buy rating.

Tenet Healthcare (THC) — Barclays raised its price target for the stock from $271.00 to $297.00 while maintaining an Overweight rating.

Teva Pharmaceutical Industries (TEVA) — TD Cowen raised its price target for the stock from $55.00 to $57.00 while maintaining a Buy rating.

Thomson Reuters (TRI) — Canaccord Genuity Group raised its price target for the stock from $129.50 to $130.50 while maintaining a Buy rating.

Thomson Reuters (TRI) — JPMorgan Chase & Co. raised its price target for the stock from $110.00 to $115.00 while maintaining a Neutral rating.

Toast (TOST) — Morgan Stanley lowered its price target for the stock from $45.00 to $42.00 while maintaining an Overweight rating.

Toast (TOST) — Needham & Company LLC reiterated its Buy rating, and revised its price target from $100.00 to $110.00.

Toast (TOST) — Piper Sandler reiterated its Overweight rating, with a price target of $39.00.

Transcat (TRNS) — Oppenheimer upgraded the stock from Market Perform to Outperform, with a price target of $115.00.

Travere Therapeutics (TVTX) — Canaccord Genuity Group raised its price target for the stock from $70.00 to $72.00 while maintaining a Buy rating.

Travere Therapeutics (TVTX) — Guggenheim lowered its price target for the stock from $89.00 to $78.00 while maintaining a Buy rating.

Twilio (TWLO) — Tigress Financial raised its price target for the stock from $255.00 to $320.00 while maintaining a Buy rating.

Uber Technologies (UBER) — BTIG Research lowered its price target for the stock from $100.00 to $90.00 while maintaining a Buy rating.

UL Solutions (ULS) — Citigroup lowered its price target for the stock from $82.80 to $81.40 while maintaining a Neutral rating.

UL Solutions (ULS) — Wells Fargo & Company raised its price target for the stock from $104.00 to $105.00 while maintaining an Overweight rating.

Ultragenyx Pharmaceutical (RARE) — Canaccord Genuity Group lowered its price target for the stock from $39.00 to $34.00 while maintaining a Buy rating.

Ultragenyx Pharmaceutical (RARE) — Morgan Stanley raised its price target for the stock from $20.00 to $22.00 while maintaining an Equal Weight rating.

Ultragenyx Pharmaceutical (RARE) — TD Cowen raised its price target for the stock from $18.00 to $19.00 while maintaining a Buy rating.

Ultragenyx Pharmaceutical (RARE) — The Goldman Sachs Group lowered its price target for the stock from $19.00 to $17.00 while maintaining a Neutral rating.

Ultragenyx Pharmaceutical (RARE) — Wedbush lowered its price target for the stock from $25.00 to $22.00 while maintaining a Neutral rating.

Ultragenyx Pharmaceutical (RARE) — Wells Fargo & Company raised its price target for the stock from $18.00 to $19.00 while maintaining an Equal Weight rating.

uniQure (QURE) — Stifel Nicolaus set a price target of $71.00.

United Dominion Realty Trust (UDR) — Royal Bank Of Canada raised its price target for the stock from $37.00 to $38.00 while maintaining a Sector Perform rating.

United Therapeutics (UTHR) — BTIG Research raised its price target for the stock from $728.00 to $768.00 while maintaining a Buy rating.

United Therapeutics (UTHR) — Raymond James Financial set a price target of $720.00.

Unum Group (UNM) — Barclays lowered its price target for the stock from $109.00 to $101.00 while maintaining an Overweight rating.

Upstart (UPST) — B. Riley Financial reiterated its Buy rating, and revised its price target from $54.00 to $42.00.

Upstart (UPST) — Bank of America reiterated its Neutral rating, with a price target of $28.00.

Upstart (UPST) — Citigroup lowered its price target for the stock from $61.00 to $46.00 while maintaining a Buy rating.

Upstart (UPST) — Mizuho set a price target of $35.00.

Upstart (UPST) — Morgan Stanley lowered its price target for the stock from $35.00 to $24.00 while maintaining an Equal Weight rating.

Upstart (UPST) — Stephens lowered its price target for the stock from $26.00 to $24.00 while maintaining an Equal Weight rating.

Upstart (UPST) — The Goldman Sachs Group lowered its price target for the stock from $28.00 to $24.00 while maintaining a Neutral rating.

Upstart (UPST) — Truist Financial lowered its price target for the stock from $40.00 to $30.00 while maintaining a Buy rating.

UWM (UWMC) — The Goldman Sachs Group reiterated its Neutral rating, with a price target of $1.50.

V2X (VVX) — BTIG Research raised its price target for the stock from $90.00 to $95.00 while maintaining a Buy rating.

Valaris (VAL) — Susquehanna raised its price target for the stock from $86.00 to $91.00 while maintaining a Neutral rating.

Varonis Systems (VRNS) — Cantor Fitzgerald lowered its price target for the stock from $55.00 to $49.75 while maintaining an Overweight rating.

Verra Mobility (VRRM) — Morgan Stanley lowered its price target for the stock from $5.00 to $3.00 while maintaining an Equal Weight rating.

Versant (VSNT) — JPMorgan Chase & Co. lowered its price target for the stock from $43.00 to $39.00 while maintaining a Neutral rating.

Vertex Pharmaceuticals (VRTX) — Barclays raised its price target for the stock from $617.00 to $626.00 while maintaining an Overweight rating.

VICI Properties (VICI) — Cantor Fitzgerald lowered its price target for the stock from $32.00 to $29.00 while maintaining an Overweight rating.

Viper Energy (VNOM) — Truist Financial raised its price target for the stock from $53.00 to $54.00 while maintaining a Buy rating.

Viridian Therapeutics (VRDN) — Needham & Company LLC raised its price target for the stock from $34.00 to $38.00 while maintaining a Buy rating.

Vistra (VST) — KeyCorp downgraded the stock from Overweight to Sector Weight.

Vital Farms (VITL) — BMO Capital Markets reiterated its Outperform rating.

Vital Farms (VITL) — Needham & Company LLC lowered its price target for the stock from $14.00 to $13.00 while maintaining a Buy rating.

VivoPower PLC Ordinary Shares (VIVO) — Noble Financial reiterated its Outperform rating.

Voyager Technologies (VOYG) — BTIG Research lowered its price target for the stock from $55.00 to $50.00 while maintaining a Buy rating.

Vulcan Materials (VMC) — Morgan Stanley lowered its price target for the stock from $321.00 to $311.00 while maintaining an Equal Weight rating.

Waters (WAT) — Barclays raised its price target for the stock from $500.00 to $530.00 while maintaining an Overweight rating.

Waters (WAT) — Citigroup raised its price target for the stock from $470.00 to $536.00 while maintaining a Buy rating.

Waters (WAT) — JPMorgan Chase & Co. raised its price target for the stock from $435.00 to $470.00 while maintaining a Neutral rating.

Waters (WAT) — KeyCorp raised its price target for the stock from $460.00 to $500.00 while maintaining an Overweight rating.

Waters (WAT) — Royal Bank Of Canada raised its price target for the stock from $475.00 to $525.00 while maintaining an Outperform rating.

Waters (WAT) — Sanford C. Bernstein reiterated its Outperform rating, with a price target of $535.00.

Waters (WAT) — Stifel Nicolaus set a price target of $470.00.

Waters (WAT) — TD Cowen raised its price target for the stock from $515.00 to $530.00 while maintaining a Buy rating.

Wayfair (W) — Gordon Haskett upgraded the stock from Hold to Buy, with a price target of $160.00.

Wayfair (W) — Raymond James Financial reiterated its Strong-Buy rating, with a price target of $135.00.

Wayfair (W) — Truist Financial set a price target of $160.00.

Waystar (WAY) — Truist Financial raised its price target for the stock from $33.00 to $35.00 while maintaining a Buy rating.

Williams Companies (WMB) — Stifel Nicolaus set a price target of $85.00.

Xometry (XMTR) — Cantor Fitzgerald raised its price target for the stock from $110.00 to $114.00 while maintaining an Overweight rating.

Xometry (XMTR) — Citigroup raised its price target for the stock from $110.00 to $132.00 while maintaining a Buy rating.

Xometry (XMTR) — Citizens Jmp raised its price target for the stock from $120.00 to $135.00 while maintaining a Market Outperform rating.

Xometry (XMTR) — JPMorgan Chase & Co. raised its price target for the stock from $120.00 to $140.00 while maintaining an Overweight rating.

Xometry (XMTR) — Rosenblatt Securities raised its price target for the stock from $120.00 to $130.00 while maintaining a Buy rating.

Xometry (XMTR) — Royal Bank Of Canada raised its price target for the stock from $100.00 to $117.00 while maintaining a Sector Perform rating.

Xometry (XMTR) — UBS Group raised its price target for the stock from $95.00 to $108.00 while maintaining a Neutral rating.

Xometry (XMTR) — Wedbush raised its price target for the stock from $126.00 to $140.00 while maintaining an Outperform rating.

XPLR Infrastructure (XIFR) — Royal Bank Of Canada lowered its price target for the stock from $14.00 to $12.00 while maintaining an Outperform rating.

XPLR Infrastructure (XIFR) — Scotiabank lowered its price target for the stock from $12.00 to $10.00 while maintaining a Sector Perform rating.

Xylem (XYL) — Argus downgraded the stock from Buy to Hold.

Yum! Brands (YUM) — BTIG Research reiterated its Neutral rating.

Yum! Brands (YUM) — Citigroup raised its price target for the stock from $163.00 to $171.00 while maintaining a Neutral rating.

Yum! Brands (YUM) — KeyCorp reiterated coverage.

Yum! Brands (YUM) — Royal Bank Of Canada raised its price target for the stock from $170.00 to $180.00 while maintaining a Sector Perform rating.

Zebra Technologies (ZBRA) — Barclays raised its price target for the stock from $416.00 to $432.00 while maintaining an Overweight rating.

Zebra Technologies (ZBRA) — BNP Paribas Exane lowered its price target for the stock from $460.00 to $455.00 while maintaining an Outperform rating.

Zebra Technologies (ZBRA) — Cfra upgraded the stock from Hold to Buy.

Zebra Technologies (ZBRA) — Citigroup lowered its price target for the stock from $400.00 to $398.00 while maintaining a Neutral rating.

Zebra Technologies (ZBRA) — Morgan Stanley raised its price target for the stock from $360.00 to $380.00 while maintaining an Equal Weight rating.

Zimmer Biomet (ZBH) — Jefferies Financial Group reiterated its Hold rating, with a price target of $120.00.

Zimmer Biomet (ZBH) — Stifel Nicolaus set a price target of $125.00.

Keep researching

Related research

Mar 6, 2025

How Trump’s Tariffs Could Shake Up Magna International’s Auto Parts Business

Oct 24, 2023

STA Research (Rank#25) Maintained “Hold” Rating on Starbucks, $110 target (SBUX:NSD)

Oct 23, 2023

Bank of Canada Looks to Pause rates as Recession Looms

Nov 3, 2026

American Analyst Updates: Nov 3rd, 2026

Nov 3, 2026

American Analyst Updates: Nov 2nd, 2026

Oct 30, 2026

American Analyst Updates: Oct 29th, 2026

A monthly perspective in your inbox.
Five research sections in the STA Research Professional Newsletter.

Read a sample →